Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-02-01

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop a pilot screening protocol, comparing cardiac point-of-care ultrasound (POCUS), electrocardiogram (EKG), serum biomarkers (N-terminal pro b-type natriuretic peptide (NT-proBNP), high sensitivity troponin (hsTn)) with formal transthoracic echocardiogram (TTE) in pregnant women with methamphetamine use.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation Cardiac Function With Echo and BNP in Obstetrical Patients With/Without Cardiac Disease

NCT00759733

Pregnancy Heart Diseases

WITHDRAWN

nuMoM2b Heart Health Study

NCT02231398

Pregnancy Complicated by Cardiovascular Disorders as Postpartum Condition, Delivered During Previous Episode Breathing-Related Sleep Disorder

COMPLETED

NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients

NCT04231591

Congenital Heart Disease Pregnancy Complications

COMPLETED

Cardiovascular Effects of Prenatal Methamphetamine Exposure

NCT04616625

Methamphetamine Abuse Newborn Complication &#X7C; Patient &#X7C; Neonatalology

COMPLETED

Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia

NCT04063397

Preeclampsia Severe or Mild Cardiac Complication

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a pilot study that examines previously undiagnosed cardiac pathology utilizing transthoracic echocardiogram (TTE) in pregnant women with chronic methamphetamine use and assesses possible screening modalities (cardiac point-of-care ultrasound (POCUS), serum biomarkers, electrocardiogram (EKG)) in identifying underlying disease in this population. As this is a prospective observational study, we will assess pregnancy-related complications and care connections in the pilot tertiary academic setting.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Methamphetamine Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older \> 20 weeks gestation admitted to the hospital
* Active patient-defined regular methamphetamine use for at least 1 year and any use within the last month
* Able to understand and provide informed consent
* Able to understand English

Exclusion Criteria

These criteria will exclude women whose medications, personal traits, obstetric conditions, or diseases could confound cardiovascular risk.

* Prescribed stimulants
* Echocardiogram or EKG previously performed during current pregnancy
* Previous diagnosis of congestive heart dysfunction
* Previous diagnosis of pulmonary hypertension
* Previous myocardial infarction
* Previous diagnosis of endocarditis
* Prior cardiac intervention (repair of cardiac congenital lesion, valve replacement or repairs, percutaneous/operative treatment of arrhythmias)
* High-risk aortopathy (Marfan syndrome, bicuspid aortopathy, prior aortic dissection)

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No